A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
Clinical trial NCT00781612 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT00781612
- Sponsor
- Genentech, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-16
- Primary completion
- 2029-09-30
- Enrollment
- 720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.